<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24962" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Meningitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hersi</surname>
            <given-names>Kenadeed</given-names>
          </name>
          <aff>Rutgers University - NJMS</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gonzalez</surname>
            <given-names>Francisco J.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kondamudi</surname>
            <given-names>Noah P.</given-names>
          </name>
          <aff>Icahn School of Medicine at Mount Sinai , The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kenadeed Hersi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Francisco Gonzalez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noah Kondamudi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24962.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>In spite of breakthroughs in diagnosis, treatment, and vaccination, in 2015 there were 8.7 million reported cases of meningitis worldwide with 379,000 subsequent deaths. This activity reviews the cause, presentation, and diagnosis of meningitis and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of meningitis.</p></list-item><list-item><p>Describe the presentation of a patient with meningitis.</p></list-item><list-item><p>Summarize the treatment of meningitis.</p></list-item><list-item><p>Describe modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by meningitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24962&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24962">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24962.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Signs and symptoms of meningeal inflammation have been recorded in countless ancient texts throughout history; however, the term 'meningitis' came into general usage after surgeon John Abercrombie defined it in 1828.</p>
        <p>Despite breakthroughs in diagnosis, treatment, and vaccination, in 2015, there were 8.7 million reported cases of meningitis worldwide, with 379,000 subsequent deaths.<xref ref-type="bibr" rid="article-24962.r1">[1]</xref><xref ref-type="bibr" rid="article-24962.r2">[2]</xref><xref ref-type="bibr" rid="article-24962.r3">[3]</xref></p>
        <p>Meningitis is a life-threatening disorder that is most often caused by bacteria or viruses. Before the era of antibiotics, the condition was universally fatal. Nevertheless, even with great innovations in healthcare, the condition still carries a mortality rate of close to 25%.</p>
      </sec>
      <sec id="article-24962.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Meningitis is defined as inflammation of the meninges. The meninges are the three membranes (the dura mater, arachnoid mater, and pia mater) that line the vertebral canal and skull&#x000a0;enclosing the brain and spinal cord. Encephalitis, on the other hand, is inflammation of the brain itself.<xref ref-type="bibr" rid="article-24962.r4">[4]</xref><xref ref-type="bibr" rid="article-24962.r5">[5]</xref></p>
        <p>Meningitis can be caused by infectious and non-infectious processes (autoimmune disorders, cancer/paraneoplastic syndromes, drug reactions).</p>
        <p>The infectious etiologic agents of meningitis include bacteria, viruses, fungi, and less commonly parasites.</p>
        <p>Risk factors for meningitis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chronic medical disorders (renal failure, diabetes, adrenal insufficiency, cystic fibrosis)</p>
          </list-item>
          <list-item>
            <p>Extremes of age</p>
          </list-item>
          <list-item>
            <p>Undervaccination</p>
          </list-item>
          <list-item>
            <p>Immunosuppressed states (iatrogenic, transplant recipients, congenital immunodeficiencies, AIDS)</p>
          </list-item>
          <list-item>
            <p>Living in crowded conditions</p>
          </list-item>
          <list-item>
            <p>Exposures:
<list list-type="bullet"><list-item><p>Travel to endemic areas (Southwestern U.S. for cocci; Northeastern U.S. for Lyme disease)</p></list-item><list-item><p>Vectors (mosquitoes, ticks)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Alcohol use disorder</p>
          </list-item>
          <list-item>
            <p>Presence of ventriculoperitoneal (VP) shunt</p>
          </list-item>
          <list-item>
            <p>Bacterial endocarditis</p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Dural defects</p>
          </list-item>
          <list-item>
            <p>IV drug use</p>
          </list-item>
          <list-item>
            <p>Sickle cell anemia</p>
          </list-item>
          <list-item>
            <p>Splenectomy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24962.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In the&#x000a0;United States, the annual incidence of bacterial meningitis is&#x000a0;approximately 1.38 cases/100,000 population with a case fatality rate of 14.3%. <xref ref-type="bibr" rid="article-24962.r6">[6]</xref></p>
        <p>The highest incidence of meningitis worldwide is in an area of sub-Saharan Africa dubbed &#x0201c;the meningitis belt&#x0201d; stretching from Ethiopia to Senegal.<xref ref-type="bibr" rid="article-24962.r7">[7]</xref><xref ref-type="bibr" rid="article-24962.r2">[2]</xref><xref ref-type="bibr" rid="article-24962.r8">[8]</xref></p>
        <p>Most common bacterial causes of meningitis in the United States are: <xref ref-type="bibr" rid="article-24962.r9">[9]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Streptococcus pneumoniae</italic> (incidence in 2010: 0.3/100,000)</p>
          </list-item>
          <list-item>
            <p>group B <italic toggle="yes">Streptococcus</italic></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Neisseria meningitidis</italic> (incidence in 2010: 0.123/100,000)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Haemophilus influenzae </italic>(incidence in 2010: 0.058/100,000)</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Listeria monocytogenes</italic>
</p>
          </list-item>
        </list>
        <p>Consider less common bacteria such as <italic toggle="yes">Staphylococcus aureus </italic>in patients with recent surgery, central lines, and trauma. <italic toggle="yes">Mycobacterium tuberculosis</italic>&#x000a0;should be considered in immunocompromised hosts. <italic toggle="yes">Borrelia burgdorferi </italic>in patients with travel to Lyme endemic areas. <italic toggle="yes">Treponema pallidum </italic>in HIV/AIDS and individuals with multiple sexual partners. <italic toggle="yes">Escherichia coli</italic> is an important pathogen in the neonatal period.</p>
        <p>The most common viral agents of meningitis are non-polio enteroviruses (group b coxsackievirus and echovirus). Other viral causes: mumps, Parechovirus, Herpesviruses (including Epstein Barr virus, Herpes simplex virus, and Varicella-zoster virus), measles, influenza, and arboviruses (West Nile, La Crosse, Powassan, Jamestown Canyon)</p>
        <p>Fungal meningitis typically&#x000a0;is associated with an immunocompromised host (HIV/AIDS, chronic corticosteroid therapy, and patients with cancer).</p>
        <p>Fungi causing meningitis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>
<italic toggle="yes">Cryptococcus neoformans</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Coccidioides immitis</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Aspergillus</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Candida</italic>
</p>
          </list-item>
          <list-item>
            <p>Mucormycosis (more common in patients with diabetes mellitus and transplant recipients; direct extension of sinus infection)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24962.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Meningitis typically occurs through two routes of inoculation:</p>
        <p>Hematogenous seeding</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacteria colonize the nasopharynx and enter the bloodstream after mucosal invasion. Upon making their way to the subarachnoid space, the bacteria cross the blood-brain barrier, causing a direct inflammatory and immune-mediated reaction.</p>
          </list-item>
        </list>
        <p>Direct contiguous spread</p>
        <list list-type="bullet">
          <list-item>
            <p>Organisms can enter the cerebrospinal fluid (CSF) via neighboring anatomic structures (otitis media, sinusitis), foreign objects (medical devices, penetrating trauma), or during operative procedures.</p>
          </list-item>
        </list>
        <p>Viruses can penetrate the central nervous system (CNS) via retrograde transmission along neuronal pathways or by hematogenous seeding.</p>
      </sec>
      <sec id="article-24962.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Meningitis can have a varied clinical presentation depending on age and immune status of the host. Symptoms typically include fever, neck pain/stiffness, and photophobia. More non-specific symptoms include headache, dizziness, confusion, delirium, irritability, and nausea/vomiting. Signs of increased intracranial pressure (altered mental status, neurologic deficits, and seizures) portend a poor prognosis.</p>
        <p>The following risk factors should increase clinical suspicion:</p>
        <list list-type="bullet">
          <list-item>
            <p>Close contact exposures (military barracks, college dorms)</p>
          </list-item>
          <list-item>
            <p>Incomplete vaccinations</p>
          </list-item>
          <list-item>
            <p>Immunosuppression</p>
          </list-item>
          <list-item>
            <p>Children younger than five years and adults older than 65 years</p>
          </list-item>
          <list-item>
            <p>Alcohol use disorder</p>
          </list-item>
        </list>
        <p>One should try to determine a history of exposures, sexual contact, animal contact, previous neurosurgical intervention, recent travel, and the season. Most viral cases tend to occur in the warmer months.</p>
        <p>In adults, the physical exam is centered on identifying focal neurologic deficits, meningeal irritation (Brudzinski and Kernig signs), and particularly in meningococcal meningitis, characteristic skin lesions (petechiae and purpura). Cranial nerve abnormalities are seen in 10%-20% of patients.&#x000a0;</p>
        <p>Signs and symptoms are less evident in neonates and infants. They can present with and without fever or hypothermia, decreased oral intake, altered mental status, irritability, bulging fontanelle. It is important to obtain a full perinatal history and vaccine records. Some causes of meningitis are vaccine-preventable such as Pneumococcus, <italic toggle="yes">Haemophilus influenzae</italic> type B, Meningococcus, Measles, and Varicella-virus.</p>
      </sec>
      <sec id="article-24962.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Meningitis is diagnosed through cerebrospinal fluid (CSF) analysis, which includes white blood cell count, glucose, protein, culture, and in some cases, polymerase chain reaction (PCR). CSF is obtained via a lumbar puncture (LP), and the opening pressure can be measured.&#x000a0;<xref ref-type="bibr" rid="article-24962.r10">[10]</xref><xref ref-type="bibr" rid="article-24962.r11">[11]</xref><xref ref-type="bibr" rid="article-24962.r12">[12]</xref></p>
        <p>Additional testing should be performed tailored on suspected etiology:</p>
        <list list-type="bullet">
          <list-item>
            <p>Viral: Multiplex and specific PCRs</p>
          </list-item>
          <list-item>
            <p>Fungal: CSF fungal culture, India ink stain for <italic toggle="yes">Cryptococcus</italic></p>
          </list-item>
          <list-item>
            <p>Mycobacterial: CSF Acid-fast bacilli smear and culture</p>
          </list-item>
          <list-item>
            <p>Syphilis: CSF VDRL</p>
          </list-item>
          <list-item>
            <p>Lyme disease: CSF <italic toggle="yes"> burgdorferi</italic> antibody</p>
          </list-item>
        </list>
        <p>The CSF findings expected in bacterial, viral, and fungal meningitis are listed in the chart: Expected CSF findings in bacterial versus viral versus fungal meningitis.</p>
        <p>Ideally, the CSF sample should be obtained before initiating antimicrobials. However, when the diagnosis of bacterial meningitis is seriously considered, and the patient is severely ill, antibiotics should be initiated before performing the LP.</p>
        <p>
<bold>Computed Tomography (CT) of the Head before Lumbar Puncture</bold>
</p>
        <p>There is controversy regarding the adage that the lumbar puncture is the inciting event causing brain herniation and death in the setting of increased intracranial pressure caused by acute bacterial meningitis.</p>
        <p>Currently, guidelines recommend empiric antibiotics and supportive care, while forgoing the lumbar puncture if there is clinical suspicion of increased intracranial pressure or impending brain herniation.</p>
        <p>Signs and symptoms of impending herniation include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Glasgow coma scale (GCS) less than 11</p>
          </list-item>
          <list-item>
            <p>Lethargy</p>
          </list-item>
          <list-item>
            <p>Altered mental status</p>
          </list-item>
          <list-item>
            <p>New-onset seizures</p>
          </list-item>
          <list-item>
            <p>Focal neurologic deficit</p>
          </list-item>
        </list>
        <p>It is important to note that&#x000a0;a normal head CT does not preclude increased intracranial pressure or impending brain herniation. If the clinical symptoms are consistent with impending herniation, regardless of whether or not the CT head is normal, avoid the LP and start treatment.</p>
        <p>Blood work should include blood culture, serum electrolytes as the syndrome of inappropriate antidiuretic hormone secretion (SIADH)&#x000a0;is not uncommon, serum glucose, renal and liver function, and testing for HIV.</p>
      </sec>
      <sec id="article-24962.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Antibiotics and supportive care are critical in all cases of bacterial meningitis.<xref ref-type="bibr" rid="article-24962.r13">[13]</xref><xref ref-type="bibr" rid="article-24962.r14">[14]</xref><xref ref-type="bibr" rid="article-24962.r15">[15]</xref></p>
        <p>Managing the airway, maintaining oxygenation, giving sufficient intravenous fluids while providing fever control are parts of the foundation of meningitis management.</p>
        <p>The type of antibiotic is based on the presumed organism causing the infection. The clinician must take into account patient demographics and past medical history in order to provide the best antimicrobial coverage.</p>
        <p>
<bold>Current Empiric Therapy</bold>
</p>
        <p>Neonates -&#x000a0;Up to 1 month old</p>
        <list list-type="bullet">
          <list-item>
            <p>Ampicillin intravenously (IV) and</p>
          </list-item>
          <list-item>
            <p>Cefotaxime (or equivalent, usually ceftazidime or cefepime) IV or gentamicin IV and</p>
          </list-item>
          <list-item>
            <p>Acyclovir IV</p>
          </list-item>
        </list>
        <p>More than 1 month old</p>
        <list list-type="bullet">
          <list-item>
            <p>Ampicillin IV and</p>
          </list-item>
          <list-item>
            <p>Ceftriaxone IV</p>
          </list-item>
        </list>
        <p>Adults (18 to 49 years old)</p>
        <list list-type="bullet">
          <list-item>
            <p>Ceftriaxone IV and</p>
          </list-item>
          <list-item>
            <p>Vancomycin IV</p>
          </list-item>
        </list>
        <p>Adults older than 50 years old and the immunocompromised</p>
        <list list-type="bullet">
          <list-item>
            <p>Ceftriaxone IV and</p>
          </list-item>
          <list-item>
            <p>Vancomycin IV and</p>
          </list-item>
          <list-item>
            <p>Ampicillin IV</p>
          </list-item>
        </list>
        <p>Meningitis associated with a foreign body (post-procedure, penetrating trauma)</p>
        <list list-type="bullet">
          <list-item>
            <p>Cefepime IV or ceftazidime IV or meropenem IV and</p>
          </list-item>
          <list-item>
            <p>Vancomycin IV</p>
          </list-item>
        </list>
        <p>Meningitis with severe penicillin allergy</p>
        <list list-type="bullet">
          <list-item>
            <p>Moxifloxacin IV and</p>
          </list-item>
          <list-item>
            <p>Vancomycin IV</p>
          </list-item>
        </list>
        <p>Fungal (Cryptococcal) meningitis</p>
        <list list-type="bullet">
          <list-item>
            <p>Amphotericin B IV and</p>
          </list-item>
          <list-item>
            <p>Flucytosine by mouth</p>
          </list-item>
        </list>
        <p>
<bold>Antibiotics</bold>
</p>
        <p>Ceftriaxone</p>
        <list list-type="bullet">
          <list-item>
            <p>Third-generation cephalosporin</p>
          </list-item>
          <list-item>
            <p>Gram-negative coverage</p>
          </list-item>
          <list-item>
            <p>Very effective against<italic toggle="yes">&#x000a0;Streptococcus pneumoniae </italic>and&#x000a0;<italic toggle="yes">Neisseria meningitidis</italic></p>
          </list-item>
          <list-item>
            <p>Better CNS penetration than piperacillin-tazobactam (typically used in gram-negative sepsis coverage)</p>
          </list-item>
        </list>
        <p>Vancomycin</p>
        <list list-type="bullet">
          <list-item>
            <p>Gram-positive coverage (MRSA)</p>
          </list-item>
          <list-item>
            <p>Also used for resistant pneumococcus</p>
          </list-item>
        </list>
        <p>Ampicillin</p>
        <list list-type="bullet">
          <list-item>
            <p>Listeria coverage (gram-positive bacilli)</p>
          </list-item>
        </list>
        <p>Cefepime</p>
        <list list-type="bullet">
          <list-item>
            <p>Fourth-generation cephalosporin</p>
          </list-item>
          <list-item>
            <p>Increased activity against pseudomonas</p>
          </list-item>
        </list>
        <p>Cefotaxime</p>
        <list list-type="bullet">
          <list-item>
            <p>Third-generation cephalosporin</p>
          </list-item>
          <list-item>
            <p>Equivalent to ceftriaxone</p>
          </list-item>
          <list-item>
            <p>Safe for neonates</p>
          </list-item>
        </list>
        <p>
<bold>Steroid Therapy</bold>
</p>
        <p>There is insufficient evidence to support the widespread use of steroids in bacterial meningitis. Some studies report a reduction in mortality for <italic toggle="yes">Streptococcus pneumoniae</italic> meningitis, but not in <italic toggle="yes">Haemophilus influenzae</italic> or <italic toggle="yes">Neisseria meningitidis</italic> meningitis. In children, steroids were associated with a reduction of severe hearing impairment only in cases of <italic toggle="yes">Haemophilus influenzae </italic>meningitis. <xref ref-type="bibr" rid="article-24962.r16">[16]</xref></p>
        <p>
<bold>Increased Intracranial Pressure</bold>
</p>
        <p>If the patient develops clinical signs of increased intracranial pressure (altered mental status, neurologic deficits, non-reactive pupils, bradycardia), interventions to maintain cerebral perfusion include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Elevating the head of the bed to 30 degrees</p>
          </list-item>
          <list-item>
            <p>Inducing mild hyperventilation in the intubated patient</p>
          </list-item>
          <list-item>
            <p>Osmotic diuretics such as 25% mannitol or 3% saline</p>
          </list-item>
        </list>
        <p>
<bold>Chemoprophylaxis</bold>
</p>
        <p>Chemoprophylaxis is indicated for close contacts of a patient diagnosed with <italic toggle="yes">N. meningitidis</italic> and <italic toggle="yes">H. influenzae</italic> type B meningitis.</p>
        <p>Close contacts include housemates, significant others, those who have shared utensils, and health care providers in proximity to secretions (providing mouth-to-mouth resuscitation, intubating without a facemask).</p>
        <p>Antibiotic chemoprophylaxis for <italic toggle="yes">N. meningitidis</italic> includes rifampin, ciprofloxacin, or ceftriaxone, and for <italic toggle="yes">H. influenzae</italic> type B: rifampin.</p>
      </sec>
      <sec id="article-24962.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Subdural hematoma</p>
          </list-item>
          <list-item>
            <p>Subarachnoid hemorrhage</p>
          </list-item>
          <list-item>
            <p>Metastatic brain disease</p>
          </list-item>
          <list-item>
            <p>Brain abscess (might coexist with meningitis)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24962.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Outcomes depend on patient characteristics such as age and immune status, but also vary depending on the etiologic organism. In the United States, for overall bacterial meningitis, the annual case fatality rate in 2010 was 14.3%.</p>
        <p>Pathogen-specific mortality:<xref ref-type="bibr" rid="article-24962.r6">[6]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Streptococcus pneumoniae </italic>meningitis: case fatality rate, 17.9%</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Neisseria meningitidis </italic>meningitis: case fatality rate, 10.1%</p>
          </list-item>
          <list-item>
            <p>Group B <italic toggle="yes">Streptococcus</italic> meningitis: case fatality rate, 11.1%</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">H.</italic> i<italic toggle="yes">nfluenzae</italic> meningitis: case fatality rate, 7%</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Listeria monocytogenes</italic> meningitis: case fatality rate, 18.1%</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24962.s11" sec-type="Complications">
        <title>Complications</title>
        <p>A metaanalysis published in 2010 from a cohort of pediatric patients reported that the median risk of sequelae post-discharge was 19.9%. In this study, the most common organism isolated was <italic toggle="yes">H. influenzae</italic>, followed by <italic toggle="yes">S. pneumoniae</italic>. The most common sequelae were hearing loss (6%), followed by behavioral (2.6%) and cognitive difficulties (2.2%), motor deficit (2.3%), seizure disorder (1.6%) and visual impairment (0.9%). <xref ref-type="bibr" rid="article-24962.r17">[17]</xref></p>
        <p>Other complications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased intracranial pressure from cerebral edema caused by increased intracellular fluid in the brain. Several factors are involved in the development of cerebral edema: increased in blood-brain barrier permeability, cytotoxicity from cytokines, immune cells, and bacteria.</p>
          </list-item>
          <list-item>
            <p>Hydrocephalus</p>
          </list-item>
          <list-item>
            <p>Cerebrovascular complications</p>
          </list-item>
          <list-item>
            <p>Focal neurologic deficits</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24962.s12" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Infectious diseases specialist in case of unidentified or rare pathogen</p>
          </list-item>
          <list-item>
            <p>Neurology to aid in seizure management</p>
          </list-item>
          <list-item>
            <p>Neurosurgery when there is suspicion of progression to brain abscess</p>
          </list-item>
          <list-item>
            <p>Rheumatology and heme/oncology in case of non-infectious cause</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24962.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Differentiating between bacterial, viral, and fungal meningitis may be difficult. CSF analysis may not be conclusive, and cultures do not immediately yield an answer. Multiplex and specific PCR panels are available and provide information in a few hours. Given the morbidity and mortality, it is prudent to initiate empiric antibiotic therapy and admit all those with suspected meningitis to the hospital on droplet precautions, until pathogen is identified, and appropriate antibiotics have been given for 24 hours.</p>
      </sec>
      <sec id="article-24962.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Meningitis is a serious disorder with high morbidity and mortality. The majority of patients with meningitis first present to the emergency department and a streamlined interprofessional approach is vital if one wants to lower the high morbidity. The triage nurse must be fully aware of the signs and symptoms of the illness and refer the patient immediately to the emergency department clinician. Other specialists who are usually involved in the care of these patients are neurologists, pediatricians, intensivists, infectious disease specialists, and pharmacists. If bacterial meningitis is suspected, prompt antibiotics should be started even in the absence of laboratory results. The pharmacist, preferably specializing in infectious diseases, should assist the clinical team in choosing the appropriate antibiotics based on the age of the patient and local sensitivities and correct dosing to ensure penetration into the central nervous system.</p>
        <p>To prevent this infection, the education of the public is vital. All healthcare workers (nurses, physicians, and pharmacists) should educate patients and parents in regards to vaccine-preventable meningitis (<italic toggle="yes">H. influenzae</italic> type B, <italic toggle="yes">S. pneumoniae</italic>, <italic toggle="yes">N. meningitidis</italic>, Measles, and Varicella). Across the board, the incidence of meningitis has decreased with the implementation of generalized vaccination. Family members should be educated about the need for prophylaxis when there is a family member with <italic toggle="yes">Neisseria</italic> and <italic toggle="yes">H. influenzae</italic> type B meningitis. All contacts should be educated about the signs and symptoms of the infection and when to return to the emergency department.<xref ref-type="bibr" rid="article-24962.r18">[18]</xref></p>
      </sec>
      <sec id="article-24962.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24962&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24962">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/meningitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24962">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24962/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24962">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24962.s16">
        <fig id="article-24962.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Neuropathology specimen, Purulent meningitis, HE Stain, Hematoxylin and Eosin stain Contributed by Wikimedia Commons, Jens Florian (CC by 4.0) https://creativecommons.org/licenses/by/4.0/</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_NP_E1_0001" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24962.s17">
        <fig id="article-24962.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Culture Plate, Meningitis; Fungal, Ascomycota, Lab Contributed by James Gathany, The Centers for Disease Control and Prevention (CDC)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="15146_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24962.s18">
        <fig id="article-24962.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Expected CSF Findings in Bacterial versus Viral versus Fungal Meningitis 2 Contributed by Kenadeed Hersi</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Screenshot__2017-09-13__18.34.32" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24962.s19">
        <fig id="article-24962.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Figure 3 has a reference of PMID 22844374, A case of carcinomatous meningitis despite prophylactic cranial irradiation in small cell lung cancer during treatment with amrubicin. Contributed by Ayesha Anwar, MBBS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Fig__3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24962.s20">
        <title>References</title>
        <ref id="article-24962.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chalimou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Krilis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Anastopoulou</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vikelis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Makridou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Makris</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Argyriou</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Acute aseptic meningitis during isotretinoin treatment for nodular acne solely presenting with headache: case report and brief review of the literature.</article-title>
            <source>Int J Neurosci</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-206</page-range>
            <pub-id pub-id-type="pmid">30160569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Incidence and aetiology of bacterial meningitis among children aged 1-59&#x0202f;months in South Asia: systematic review and meta-analysis.</article-title>
            <source>Vaccine</source>
            <year>2018</year>
            <month>Sep</month>
            <day>18</day>
            <volume>36</volume>
            <issue>39</issue>
            <fpage>5846</fpage>
            <page-range>5846-5857</page-range>
            <pub-id pub-id-type="pmid">30145101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giovane</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lavender</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Central Nervous System Infections.</article-title>
            <source>Prim Care</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>505</fpage>
            <page-range>505-518</page-range>
            <pub-id pub-id-type="pmid">30115337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lalk</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Infection and metabolism - Streptococcus pneumoniae metabolism facing the host environment.</article-title>
            <source>Cytokine</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>112</volume>
            <fpage>75</fpage>
            <page-range>75-86</page-range>
            <pub-id pub-id-type="pmid">30077545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bagga</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Diaz-Thomas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intracranial pathologies associated with central diabetes insipidus in infants.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2018</year>
            <month>Sep</month>
            <day>25</day>
            <volume>31</volume>
            <issue>9</issue>
            <fpage>951</fpage>
            <page-range>951-958</page-range>
            <pub-id pub-id-type="pmid">30052518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thigpen</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Whitney</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Messonnier</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Zell</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Lynfield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hadler</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Farley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Reingold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Schaffner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Scallan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schuchat</surname>
                <given-names>A</given-names>
              </name>
              <collab>Emerging Infections Programs Network</collab>
            </person-group>
            <article-title>Bacterial meningitis in the United States, 1998-2007.</article-title>
            <source>N Engl J Med</source>
            <year>2011</year>
            <month>May</month>
            <day>26</day>
            <volume>364</volume>
            <issue>21</issue>
            <fpage>2016</fpage>
            <page-range>2016-25</page-range>
            <pub-id pub-id-type="pmid">21612470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadeghi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmadrajabi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dehesh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saffari</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of meningococcal carriage among male university students living in dormitories in Kerman, southeast of Iran.</article-title>
            <source>Pathog Glob Health</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>112</volume>
            <issue>6</issue>
            <fpage>329</fpage>
            <page-range>329-333</page-range>
            <pub-id pub-id-type="pmid">30156971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chauhan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mokta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kanga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, clinical profile and role of rapid tests in the diagnosis of acute bacterial meningitis in children (aged 1-59 months).</article-title>
            <source>Neurol India</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>1045</fpage>
            <page-range>1045-1049</page-range>
            <pub-id pub-id-type="pmid">30038091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castelblanco</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>813</fpage>
            <page-range>813-9</page-range>
            <pub-id pub-id-type="pmid">25104307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000fc;ldemir</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bakkalo&#x0011f;lu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Nar &#x000d6;tg&#x000fc;n</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Durmaz</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Optimization of real-time multiplex polymerase chain reaction for the diagnosis of acute bacterial meningitis and Neisseria meningitidis serogrouping].</article-title>
            <source>Mikrobiyol Bul</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>221</fpage>
            <page-range>221-232</page-range>
            <pub-id pub-id-type="pmid">30156509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hussien</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ali-Eldin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Adel</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>ASSESSMENT OF THE DIAGNOSTIC AND PROGNOSTIC ROLE OF CEREBEROSPINAL FLUID INTERLEUKIN-8 LEVEL IN ADULT PATIENTS WITH MENINGITIS.</article-title>
            <source>J Egypt Soc Parasitol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>361</fpage>
            <page-range>361-366</page-range>
            <pub-id pub-id-type="pmid">30152945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Shorbagy</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Barseem</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Abdelghani</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Suliman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Al-Shokary</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Elsadek</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Maksoud</surname>
                <given-names>YHA</given-names>
              </name>
              <name>
                <surname>Sabri</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The value of serum procalcitonin in acute meningitis in children.</article-title>
            <source>J Clin Neurosci</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>56</volume>
            <fpage>28</fpage>
            <page-range>28-33</page-range>
            <pub-id pub-id-type="pmid">30143413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Nervous System Infections and the Global Traveler.</article-title>
            <source>Semin Neurol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-262</page-range>
            <pub-id pub-id-type="pmid">29791951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>GQ</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Lyu</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>QQ</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>TS</given-names>
              </name>
              <collab>Society of Infectious Diseases, Chinese Medical Association</collab>
            </person-group>
            <article-title>[Expert consensus on the diagnosis and treatment of cryptococcal meningitis].</article-title>
            <source>Zhonghua Nei Ke Za Zhi</source>
            <year>2018</year>
            <month>May</month>
            <day>01</day>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>317</fpage>
            <page-range>317-323</page-range>
            <pub-id pub-id-type="pmid">29747285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dretler</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Rouphael</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Stephens</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.</article-title>
            <source>Hum Vaccin Immunother</source>
            <year>2018</year>
            <month>May</month>
            <day>04</day>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>1146</fpage>
            <page-range>1146-1160</page-range>
            <pub-id pub-id-type="pmid">29543582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouwer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids for acute bacterial meningitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Sep</month>
            <day>12</day>
            <volume>2015</volume>
            <issue>9</issue>
            <fpage>CD004405</fpage>
            <pub-id pub-id-type="pmid">26362566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edmond</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Korczak</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Sanderson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Rudan</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2010</year>
            <month>May</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>317</fpage>
            <page-range>317-28</page-range>
            <pub-id pub-id-type="pmid">20417414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24962.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munguambe</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>AECC</given-names>
              </name>
              <name>
                <surname>Nhantumbo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Come</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Zimba</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Paulo Langa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Filippis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gudo</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>e0197390</fpage>
            <pub-id pub-id-type="pmid">30089105</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
